Report cover image

Allergy Treatment Market

Published Apr 01, 2026
Length 135 Pages
SKU # IMRC21081736

Description

The global allergy treatment market size reached USD 24.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 37.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.72% during 2026-2034.

Allergy treatment is a preventive medical cure for abnormal reactions to allergens, such as pollens, molds, animal dander, latex, insects, food, and medications. They trigger the release of histamine by the immune system that causes inflammation, rashes, itchiness, sneezing, runny nose, and red eyes. They can also cause various allergic conditions, including hay fever, asthma, rhinitis, and skin, food, and eye allergies. Allergy treatment includes anti-allergic drugs and immunotherapy that can be administered through oral, inhalers, and intranasal dosage forms. These treatment methods help reduce sensitivity and inflammation, decrease symptoms, and improve the quality of the patient’s life.

ALLERGY TREATMENT MARKET TRENDS:

The increasing prevalence of various allergies across the globe is one of the primary factors driving the market growth. In line with this, favorable initiatives by governments and non-governmental organizations (NGOs) to sensitize the masses about the adversities of allergies and their appropriate treatment options are favoring the market growth. Furthermore, increasing demand for over-the-counter (OTC) drugs, coupled with a growing inclination toward self-medication among consumers, is acting as another growth-inducing factor. Additionally, the integration of artificial intelligence (AI), natural language processing (NLP), and machine learning (ML) for diagnosing allergic diseases, predicting patient outcomes for targeted interventions, analyzing immunological data, and improving care delivery is providing an impetus to market growth. Apart from this, the increasing demand for subcutaneous allergen-specific immunotherapy (SCIT) due to its effectiveness, safety, and ability to alter the immune system and provide systemic relief is creating a positive outlook for the market. Other factors, including significant healthcare expenditures, increasing geriatric population, extensive research and development (R&D) activities towards novel treatments, and rising incidences of asthma, are anticipated to drive the market growth.

KEY MARKET SEGMENTATION:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy treatment market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on type, treatment, dosage form and distribution channel.

Breakup by Type:
  • Eye Allergy
  • Skin Allergy
  • Food Allergy
  • Asthma
  • Rhinitis
  • Others
Breakup by Treatment:
  • Anti-Allergy Drugs
  • Immunotherapy
Breakup by Dosage Form:
  • Oral
  • Inhalers
  • Intranasal
  • Others
Breakup by Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Retailers
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
COMPETITIVE LANDSCAPE:

The report provides a comprehensive analysis of the competitive landscape in the global allergy treatment market with detailed profiles of all major companies, including:
  • AbbVie Inc.
  • ALK-Abelló A/S
  • ALLERGOPHARMA GmbH & Co. KG
  • Almirall, S.A
  • DBV Technologies
  • GSK plc.
  • HAL Allergy B.V.
  • Nicox
  • Novartis Pharmaceuticals Corporation
  • Stallergenes Greer
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global allergy treatment market in 2025?

2. What is the expected growth rate of the global allergy treatment market during 2026-2034?

3. What are the key factors driving the global allergy treatment market?

4. What has been the impact of COVID-19 on the global allergy treatment market?

5. What is the breakup of the global allergy treatment market based on the type?

6. What is the breakup of the global allergy treatment market based on the treatment?

7. What are the key regions in the global allergy treatment market?

8. Who are the key players/companies in the global allergy treatment market?

Table of Contents

135 Pages
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Allergy Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Eye Allergy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Skin Allergy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Food Allergy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Asthma
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Rhinitis
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Treatment
7.1 Anti-Allergy Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Immunotherapy
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Dosage Form
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Inhalers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Intranasal
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Retailers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 ALK-Abelló A/S
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 ALLERGOPHARMA GmbH & Co. KG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Almirall, S.A
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 DBV Technologies
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 GSK plc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 HAL Allergy B.V.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Nicox
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Novartis Pharmaceuticals Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Stallergenes Greer
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Teva Pharmaceutical Industries Ltd.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Viatris Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.